Charles River Laboratories
CRL
NZ$265.29
Share price
-2.60%
Change (1 day)
-23.03%
Change (1 year)
Categories
Charles River Laboratories (CRL) - Total debt
Total debt on the balance sheet as of March 2025 : NZ$4.96 Billion
According to Charles River Laboratories 's latest financial reports the company's total debt is NZ$4.96 Billion. A company’s total debt is the sum of all current and non-current debts.
Charles River Laboratories - Total debt on balance sheet (from 2000 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | NZ$4.83 B | -0.39% |
| 2023-12-31 | NZ$4.84 B | -0.61% |
| 2022-12-31 | NZ$4.87 B | 14.25% |
| 2021-12-31 | NZ$4.26 B | 42.63% |
| 2020-12-31 | NZ$2.99 B | -0.43% |
| 2019-12-31 | NZ$3.00 B | 20.9% |
| 2018-12-31 | NZ$2.48 B | 54.23% |
| 2017-12-31 | NZ$1.61 B | -9.57% |
| 2016-12-31 | NZ$1.78 B | 41.39% |
| 2015-12-31 | NZ$1.26 B | 27.9% |
| 2014-12-31 | NZ$0.98 B | 22.05% |
| 2013-12-31 | NZ$0.80 B | -0.3% |
| 2012-12-31 | NZ$0.81 B | -11.92% |
| 2011-12-31 | NZ$0.91 B | 1.26% |
| 2010-12-31 | NZ$0.90 B | 33.88% |
| 2009-12-31 | NZ$0.67 B | -31.65% |
| 2008-12-31 | NZ$0.99 B | 49.09% |
| 2007-12-31 | NZ$0.66 B | -18% |
| 2006-12-31 | NZ$0.81 B | 87.4% |
| 2005-12-31 | NZ$0.43 B | -54.98% |
| 2004-12-31 | NZ$0.96 B | 236.98% |
| 2003-12-31 | NZ$0.28 B | -22.34% |
| 2002-12-31 | NZ$0.36 B | -2.6% |
| 2001-12-31 | NZ$0.37 B | -17.53% |
| 2000-12-31 | NZ$0.45 B | -38.01% |
| 1999-12-31 | NZ$0.73 B | 24507.83% |
| 1998-12-31 | NZ$3 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Repligen
RGEN | NZ$1.13 B | -77.10% | 🇺🇸 USA |
 SCYNEXIS SCYX | NZ$4.13 M | -99.92% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | NZ$56.90 B | 1,045.03% | 🇺🇸 USA |